The estimated Net Worth of William J Newell is at least $4.86 Milion dollars as of 5 March 2024. Mr. Newell owns over 18,750 units of Sutro Biopharma Inc stock worth over $1,045,977 and over the last 6 years he sold STRO stock worth over $0. In addition, he makes $3,817,120 as Chief Executive Officer a Director at Sutro Biopharma Inc.
Sign up
Mr. Newell STRO stock SEC Form 4 insiders trading
William has made over 14 trades of the Sutro Biopharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 18,750 units of STRO stock worth $86,438 on 5 March 2024.
The largest trade he's ever made was buying 64,516 units of Sutro Biopharma Inc stock on 14 May 2020 worth over $499,999. On average, William trades about 15,797 units every 74 days since 2018. As of 5 March 2024 he still owns at least 226,893 units of Sutro Biopharma Inc stock.
You can see the complete history of Mr. Newell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Newell biography
William J. Newell J.D. is Chief Executive Officer and Director of the Company. Previously, he served as the President of Aerovance, Inc., a biotechnology company focused on respiratory diseases, from 2006 to 2007. Mr. Newell has also served as the Chief Business Officer and Senior Vice President at QLT Inc., in several senior management positions at Axys Pharmaceuticals, Inc., and has experience as a corporate lawyer. He currently serves on the boards of directors of a private biotechnology company, the Biotechnology Innovation Organization’s Health Section and Emerging Company Section and the California Life Sciences Association, where he also serves as a member of the executive committee. Mr. Newell received an A.B. in Government from Dartmouth College and a J.D. from the University of Michigan Law School.
What is the salary of William Newell?
As the Chief Executive Officer a Director of Sutro Biopharma Inc, the total compensation of William Newell at Sutro Biopharma Inc is $3,817,120. There are no executives at Sutro Biopharma Inc getting paid more.
How old is William Newell?
William Newell is 62, he's been the Chief Executive Officer a Director of Sutro Biopharma Inc since 2009. There are 11 older and 6 younger executives at Sutro Biopharma Inc. The oldest executive at Sutro Biopharma Inc is Dr. Shabbir T. Anik, 68, who is the Chief Technical Operations Officer.
What's William Newell's mailing address?
William's mailing address filed with the SEC is C/O SUTRO BIOPHARMA, INC., 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Insiders trading at Sutro Biopharma Inc
Over the last 6 years, insiders at Sutro Biopharma Inc have traded over $14,451,171 worth of Sutro Biopharma Inc stock and bought 750,858 units worth $10,652,478 . The most active insiders traders include Corp /De/ Celgene, John Gordon Freund a Daniel Janney. On average, Sutro Biopharma Inc executives and independent directors trade stock every 19 days with the average trade being worth of $129,762. The most recent stock trade was executed by Jane Chung on 9 August 2024, trading 18,750 units of STRO stock currently worth $86,438.
What does Sutro Biopharma Inc do?
at sutro biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. our focus is aimed primarily on next generation cancer therapeutics — antibody conjugates and bispecific antibodies. unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell. our technology enables us to iteratively discover and test molecules in a rapid cycle of weeks rather than months, to rapidly identify the optimal molecule designed for safety and potency. our approach to discovery, without the cell, is also transcending the the limitations of biologics manufacturing. sutro has the world’s only cgmp cell-free manufacturing facility located in san carlos, california. this state-of- the-art facility confers an important competitive advantage as we head into human clinical trials in 2018. in addition to developing our own oncology pipeline, sutro biopharma is coll
What does Sutro Biopharma Inc's logo look like?
Complete history of Mr. Newell stock trades at Sutro Biopharma Inc a Vaxcyte
Sutro Biopharma Inc executives and stock owners
Sutro Biopharma Inc executives and other stock owners filed with the SEC include:
-
William Newell,
Chief Executive Officer, Director -
William J. Newell J.D.,
CEO & Director -
Trevor Hallam,
Chief Scientific Officer -
Arturo Molina,
Chief Medical Officer -
William J. Newell,
CEO & Director -
Jane Chung R.Ph.,
Chief Commercial Officer -
Dr. Trevor J. Hallam,
Pres of Research & Chief Scientific Officer -
Linda A. Fitzpatrick,
Chief People & Communications Officer -
Connie Matsui,
Chairman of the Board -
Shalini Sharp,
Independent Director -
Joseph Lobacki,
Independent Director -
Michael Dybbs,
Independent Director -
John Freund,
Independent Director -
Daniel Petree,
Director -
Annie Chang,
Head of Investor Relations -
Diana Landa,
Vice President of Regulatory Affairs -
James Panek,
Director -
Shabbir Anik,
Chief Technical Operations Officer -
Brunilda Shtylla,
Vice President - Business Development -
Craig Berman,
Vice President - Clinical Development -
Kristin Bedard,
Vice President - Immunobiology -
Carlos Lugo,
Vice President - Quality and CMC Regulatory Operations -
Regina Cheng,
Vice President - Finance, Controller -
Linda Fitzpatrick,
Chief People and Communications Officer -
Edward Albini,
Chief Financial Officer -
Dr. James R. Swartz Ph.D., Sc.D.,
Founder -
Dr. Arturo M. Molina FACP, M.D., MS,
Chief Medical Officer -
Annie J. Chang M.B.A.,
VP of Investor Relations -
Dr. Arturo M. Molina,
Chief Medical Officer -
Dr. Nicki Vasquez Ph.D.,
Chief Portfolio Strategy & Alliance Officer -
David Pauling J.D., M.A.,
Gen. Counsel -
Dr. Shabbir T. Anik,
Chief Technical Operations Officer -
Edward C. Albini,
CFO & Sec. -
Dr. James R. Swartz,
Founder and Member of Scientific Advisory Board -
Nicki Vasquez,
CHIEF PORT. STRAT & ALNCE OFCR -
Corp /De/ Celgene,
-
Michael Jay Ross,
Director -
Partners Viii, L.P.Alta Par...,
-
V Bryan Lawlis,
Director -
Daniel Janney,
Director -
Stephen Worsley,
Chief Business Officer -
& Co., Inc.Merck Sharp & Do...,
-
Venture Partners V Lp Skyli...,
-
V, Llcilsf Iii, Llcinternat...,
-
Jane Chung,
PRESIDENT AND COO -
Venkatesh Srinivasan,
CHIEF TECH OP OFFICER -
Anne Elizabeth Borgman,
CHIEF MEDICAL OFFICER -
Sukhi Jagpal,
-
Hans Peter Gerber,
CHIEF SCIENTIFIC OFFICER -
Heidi Hunter,
-
Jon Marc Wigginton,
-
Barbara Leyman,
Chief Business Dev. Officer